. In Group II, the pregnancy and miscarriage rates were similar to those of the frozen embryo cycles at Bourn Hall (30.4 and 14.3 vs 22.3 and 12.1%, respectively). Conclusions: Small endometrial polyps, less than 2 cm, do not decrease the pregnancy rate, but there is a trend toward increased pregnancy loss. A policy of oocyte retrieval, polypectomy, freezing the embryos, and replacing them in the future might increase the "take-home baby" rate.
INTRODUCTION
Despite much progress in the earlier days of in vitro fertilization (IVF), such as ovulation induction, oocyte retrieval, and culture medium, the maximum conception rate still does not usually exceed 30% per embryo ' Bourn Hall Clinic, Bourn, Cambridge CB3 7TR, UK. 2 To whom correspondence should be addressed.
l058-0468/99/0900-04I0$l6.00/0 C 1999 Plenum Publishing Corporation 410 transfer and at least 90% of apparently normal embryos fail to implant (1) . Structural pathology in the uterine cavity may play an important role in subfertility, implantation failure, or miscarriage. However, the role of the endometrial polyp(s) in reproductive failure is not clear and is probably underestimated. Surprisingly there is a lack of data regarding the effect of polyps on the implantation rate or pregnancy outcome in IVF. The incidental finding of an endometrial polyp in an IVF cycle presents a management dilemma to the medical team and their patients. The aim of this retrospective study was to evaluate (a) the pregnancy rate and outcome after embryo transfer without removal of the polyps and (b) the possible beneficial approach of performing hysteroscopy and polypectomy immediately following oocyte retrieval, freezing all embryos (FAE), and replacing them a few months later.
MATERIALS AND METHODS

Subjects
The data from 5736 oocyte recovery cycles for IVF performed at Bourn Hall Clinic during the period January 1991 to May 1997 were analyzed retrospectively. In 83 of these cycles (1.4%), an endometrial polyp was suspected and recorded.
A polyp was diagnosed if an hyperechoic endometrial mass was found by transvaginal sonography. An Hitachi EUB 515 ultrasound scanner (Hitachi, Japan) with a 5-MHz transvaginal transducer was used. Most of the scans were performed by the same author (G.W). Each polyp was measured in three planes-maximal longitudinal, anteroposterior, and transverse-and the average diameter was calculated. In a few other cycles in which polyps larger than 20 mm were identified, the cycles were abandoned pending further investigation and treatment; they are excluded from this study.
Immediately after detection of an intrauterine polyp, either at the time of the "baseline" scan following gonadotropin-releasing hormone (GnRH) agonist treatment (40 cycles; 48.2%) or during the ovulation induction monitoring period (43 cycles; 51.8%). Patients had a detailed discussion with their doctor and were given the choice of (a) proceeding with the IVF cycle to embryo replacement (Group I) or (b) proceeding to oocyte recovery, hysteroscopy and polypectomy in the same procedure, followed by insemination of the oocytes and freezing of the resulting embryos with the intention of performing frozen embryo replacement (FER) in the future (Group II). We did not recommend embryo replacement in the cycle of the hysteroscopy and polypectomy because of the risk of jeopardizing implantation due to endometrial bleeding. The decision on which action line to embark on was made by the patients before oocyte recovery with advice from their doctor that there are currently no data available in the literature regarding the effect of the polyp(s) and therefore the "best" option is not clear.
Ovulation Induction Protocol
A GnRH agonist, either buserelin (Supercur; Shire Pharmaceuticals Ltd., East Anton, Andover, Hants, UK) or naferaline (Synarel; Searle, High Wycombe, UK). Follicle stimulating hormone (FSH), highly purified FSH, or recombinant human FSH (Metrodin, Metrodin HP, or Gonal-F; Serono Laboratories Ltd., Welwyn Garden City, UK) was used for follicular stimulation in all 83 cycles. The regimes for ovarian stimulation and cycle monitoring have been described previously (2, 3) . Transvaginal ultrasound assessment of follicular growth, and endometrial thickness and measurement of estradiol (E 2 ) levels were begun on stimulation day 8. Human chorionic gonadotropin (hCG; Profasi; Serono), 10,000 IU, was injected intramuscularly or subcutanously when there were at least three follicles > 16 mm in average diameter. Transvaginal ultrasound-directed oocyte recovery under general anesthesia was performed 32-36 hr after the hCG injection. In vitro culture and insemination were carried out according to our normal laboratory procedure (4) . In all 49 Group I cycles, fertilization was achieved and up to three embryos were transferred to the uterus 48-52 hr after oocyte collection. Luteal-phase support was provided with progesterone suppositories, either Cyclogest (Shire Pharmaceuticals Ltd.), 400 mg bd, or Utrogestan (Besins, Laboratory Besins, Iscovesco, Paris, France), 200 mg tid, for 15 days. Vol. 16, No. 8, 1999 Hysteroscopy and D&C The 34 women in Group II had an hysteroscopy immediately after their oocyte recovery. The cervix was dilated to Hegar 7 and a 6-tnm rigid hysteroscope (Karl Storz Endoscopy America Inc., Culver City, CA) was inserted under direct vision. Saline solution was used as the distension medium. The entire uterine cavity was inspected for the presence of polyps, the instrument withdrawn, and the polyps removed by ovum forceps followed by endometrial curettage. The hysteroscope was inserted again to ensure complete removal of all polyps. All endometrial samples were fixed in buffered formaldehyde, sectioned, and stained in hematoxylin-eosin for histological examination.
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Cryopreservation of Embryos
In Group II the oocytes of five patients failed to fertilize, and in a sixth the sole embryo was not suitable for cryopreservation. In 28 cycles, 155 embryos (mean = 5.5, range = 1-15) at the pronucleate stage were cryopreserved in 1.5 M propanediol (4).
Frozen Embryo Replacement (FER)
Of the 28 patients in Group II, 5 women, 2 of whom had only one embryo frozen, declined to have the embryos back for various personal reasons. Twentythree patients intended to start an FER cycle at least 3 months after oocyte retrieval. The embryos were replaced in either a "natural" monitored cycle or hormone-controlled cycles, as described previously by Sathanandan et al., (5) .
Pregnancy Monitoring
Plasma samples were taken from the women 14 days after embryo transfer for measurement of hCG and progesterone concentrations. If hCG levels were >10 IU/L, then monitoring was continued at 5-day intervals. A transvaginal scan was performed about 35 days after embryo transfer to confirm the pregnancy. Clinical pregnancy was defined as the presence in the uterus of a fetus within a gestation sac, with evidence of fetal cardiac activity. Transient rises in hCG ("biochemical pregnancy") without evidence of a gestation sac, "blighted ova," or ectopic pregnancies were recorded but are not included in this analysis of data.
Statistical Analysis
The patients' age, fertility, obstetric history, total amount of FSH used, length of stimulation, peak E 2 levels, thickness of the endometrium, number of follicles aspirated, number of oocytes recovered, and number of embryos replaced were recorded. Fertilization and pregnancy rates were calculated. The data were statistically analyzed by the unpaired Student t-test and chi-square test where appropriate. A P value of <0.05 was considered significant.
RESULTS
The two groups were similar in their age, obstetric history, and number of previous IVF attempts, as well as their response to superovulation ( Table I ). The mean average diameter of the polyps in Group II was bigger than in Group I (11.8 ± 3 vs 9.5 ± 3.2 mm; P = 0.002), although none of the polyps was larger than 20 mm. This difference might be a result of the shared decision of the patients and doctors to freeze all embryos (FAE) in these cases of larger polyps.
In five cycles in Group II (14.7%), none of the oocytes fertilized, while in Group I fertilization was achieved in all 49 cycles; therefore, the mean fertilization rate was lower in Group II, although without statistical significance. The cause of this difference is not clear, because the decision to FAE was made before the injection of hCG. Hysteroscopy and curettage were performed immediately following oocyte recovery thus, the fertilization data were not known until much later and had no effect on the allocation of patients to the two groups.
Hysteroscopy confirmed the ultrasound findings in more than 90% of cases. It is often difficult to distinguish between a true polyp and polypoid endometrium by ultrasound, especially after superovulation, which causes a thick late-proliferative endometrium. In five procedures hysteroscopy revealed polypoid endometrium and in only three cases the hysteroscopy showed a normal endometrium. The prevalence of polyps diagnosed by hysteroscopy was similar whether they were detected in the baseline scan (78.6%) or through monitoring of the superovulation phase (72.2%; Table II ). There were no other abnormalities such as fibroids or intrauterine adhesions.
In all 34 endometrial samples from Group II there was no evidence of endometritis, hyperplasia, or neoplasia. Of the 24 cases with polyps identified by hysteroscopy; endometrial polyps were confirmed by histopathology examination in 14 samples (58.3%). A polyp was not found in the specimens from eight patients in whom the hysteroscopy excluded an endometrial polyp.
In Group I all cycles reached the embryo transfer stage. The implantation rate was 9.3% (12 embryos with a fetal heart of 129 embryos transferred). Eleven women achieved clinical pregnancies (22.4% per oocyte retrieval and per embryo transfer) and eight delivered at term, including one set of twins. Three pregnancies miscarried in the first trimester (27.2%). Over the same period, similar implantation rates (12.7%) and clinical pregnancy and miscarriage rates (1055 pregnancies in 4493 embryo transfer cycles and 113 miscarriages; 23.4 and 10.7%, respectively; P = 0.08) were achieved at Bourn Hall Clinic (Table III) .
In twenty three patients of Group II, (FER) cycles were attempted, but in two cases (8.7%) the embryos failed to thaw (one embryo for one patient and five for the other). Seven women achieved clinical pregnancies endometrium, in which case they respond only to the growth effect of estrogen, without any progesterone response (the most common type), or functional endometrium, which responds to ovarian hormones similarly to the general endometrium (6) . Therefore, during the ovulation induction period, with high doses of estrogen as in IVF cycles, the thickened endometrium might mistakenly be considered a polyp or polypoid endometrium on transvaginal ultrasonography (7). Recently, Kupfer et al. (8) demonstrated that transvaginal ultrasound is an accurate method to detect benign endometrial polyps, with a good correlation to hysteroscopic and histologic findings. Almost all of these masses were significantly less than 2 cm in size and were discrete foci. Furthermore, even small lesions, less than 1 cm in size, were easily identified. The best method of diagnosing polyps is by hysteroscopy (9, 10) . Both late-proliferative and secretory endometrium may have an appearance similar to that of endometrial polyps, viewed by ultrasound and/or hysteroscopy. At hysteroscopy in the premenstrual phase the endometrium is often thrown into folds, which produces a polypoid appearance. This procedure is therefore usually performed in the postmenstrual phase of the cycle. In this study, on the contrary, the hysteroscopy was done after FSH superovulation for IVF in the presence of supraphysiological levels of estrogen and about 36 hr after hCG injection, when the endometrium was relatively thick. It may be therefore that a few of the "polyps" were in fact genuine polypoid endometrium. In only three cases (9.4%) was the conclusion of the hysteroscopist normal endometrium.
Endometrial polyps can be removed by blind curettage, but many are missed (11, 13) , and therefore, they are more successfully treated with hysteroscopic guidance (11) or curettage followed by reintroducing the hysteroscope to ensure that all the lesions have been removed (13) . The histological confirmation of a polyp in only 58% of cases when a polyp was confirmed by hysteroscopy might have resulted from misdiagnosis (30.4%; implantation rate = 16.7%), one woman miscarried (14.3%), and six have delivered, including one healthy set of triplets (Table III) . There was no difference in pregnancy rates between the natural monitored and the hormone-controlled (2/6 vs 5/15, respectively) cycles. These implantation, pregnancy, and miscarriage rates were similar to our results of 597 pregnancies including 72 miscarriages of 2674 FER cycles in the same period (12.4, 22.3, and 12.1%, respectively; P = NS).
In total, five cycles resulted in biochemical pregnancies, four in Group I and one in the FAE cycles (8.1 vs 4.8%, respectively; P = NS). There were no ectopic pregnancies in this study.
DISCUSSION
Endometrial polyps are usually asymptomatic incidental findings in assisted reproduction technology cycles. The term polyp is a clinical rather than a pathological one, referring simply to a growth which is attached by a pedicle, and not indicative of any histological feature. Polyps can be made up of immature of polypoid endometrium as a true polyp or from our method of blind curettage after hysteroscopy, especially with the smaller polyps.
Uterine anomalies, fibroids, intrauterine synechiae, and endometrial polyps are commonly considered to be closely associated with spontaneous and recurrent miscarriages, although there is still controversy about their incidence, classification, and role in reproductive failure (14) and, especially, in IVF treatment. Diagnostic hysteroscopy before IVF revealed intrauterine pathology (mainly adhesions) in up to 50% of patients (15) (16) (17) (18) (19) and a similar frequency in women who failed to conceive in one (17) or two (20) IVF cycles. Moreover, Dicker et al. (21) showed that in women with a previously normal hysteroscopy followed by three or more consecutive failed IVF-embryo transfer cycles, 18.2% demonstrated abnormalities on repeat hysteroscopy. Golan et al. (17) described a 22% pregnancy rate in IVF following surgical correction of intrauterine anomalies. In all these studies and others the abnormal uterine pathology findings were adhesions, septa, and fibroids, with very few endometrial polyps.
Endometrial polyps have been reported to occur in up to 24% of symptomatic patients (22) , however, their incidence in the reproductive life span of the general population is not known. Taylor et al. (23) showed that the frequency of endometrial polyps in infertile women and women requesting reversal of sterilization (and, hence, probably fertile) was similar. We found endometrial polyps in 1.4% of patients who had IVF treatment. This is the first study, to our knowledge, that has investigated the effect of endometrial polyps on pregnancy outcome in an IVF program. The pregnancy rate in the group of patients that proceeded to fresh embryo transfer was similar to the overall figures at Bourn Hall Clinic. It seems that endometrial polyps smaller than 2 cm have no deleterious effect on conception following IVF treatment. The nearly three times higher miscarriage rate in Group I compared to our general IVF population (27.3 vs 10.3%) was not significant, probably due to the relatively small number of patients. Power calculation shows that a minimum of 15 women conceiving with a polyp(s) with a similar miscarriage rate would be required to reach statistical significance of 0.05.
In summary, we have shown that transvaginal ultrasound is a reliable method of detecting endometrial polyps before and through superovulation cycles for IVF. Small polyps, less than 2 cm, do not decrease the implantation or pregnancy rate but may be a cause for increased pregnancy loss. We think that the presence of a small endometrial polyp before or through the Journal of Assisted Reproduction and Genetics, Vol. 16, No. 8, 1999 stimulation for IVF should not alter the planned oocyte recovery and embryo transfer, however, further prospective and, preferably, multicentric collaborative studies are required to confirm these findings.
